Newly Approved Shingles Vaccine receives ACIP preference

on Oct 25, 2017 in news

10/25/17

 

The Advisory Committee on Immunization Practices (ACIP) gives their recommendation and preference of Shingvax vaccine over current shingles vaccine, Zostavax.  This vote was due to the impressive 90% efficacy demonstrated by Shingvax.  This information will be published in the upcoming issue of the Morbidity and Mortality Weekly Report.  Read more